|
|
RNL Bio Company Limited - Comparative Business Analysis Snapshot
Business Description
RNL Bio Company Limited. The Group's principal activity is manufacturing cell therapy products. Its products include stem cells, lipostem-DM remedy for diabetes mellitus, astrostem remedy for spinal cord injury, vascostem remedy for ischemic cardiac and cerebral infarction and cancerstem remedy for cancers, endocrine remedy for anti-diabetes mellitus and bio safety products.
Competitor Analysis
This analysis compares RNL Bio Company Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
